Breaking News

Gentris Opens Biomarker Lab in Shanghai

November 21, 2013

Will provide GCLP-compliant testing and biobanking services

Gentris Corp. has opened a new genomic biomarker testing and biorepository services lab in Shanghai, China. Gentris Shanghai will provide GCLP-compliant testing and biobanking services for global pharmaceutical clients under international standards.
 
"The launch of Gentris Shanghai is a tremendous milestone for our company," said Dr. Amelia Wall Warner, Gentris president and chief executive officer. "Gentris is creating an international quality, global organization capable of providing genomic biomarker testing and biobanking services for clinical trials. In addition to commercial services, we are building collaborations with top Chinese research organizations, universities, and companies to accelerate drug development and innovation."
 
Initial services will include biobanking and nucleic acid prep, with genotyping and gene expression services to launch in 2014 with phased implementation based on demand.
  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research